Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ProText Mobility Inc (PK) | TXTM | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.001 | 07:21:45 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.001 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.0001 - 0.0031 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.001 | USD |
ProText Mobility Inc (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 8.37M | 8.37B | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ProText Mobility (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TXTM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0007 | 0.001 | 0.0007 | 0.0009287 | 1,589,983 | 0.0003 | 42.86% |
| 1 Month | 0.0005 | 0.001 | 0.0001 | 0.0008006 | 3,052,753 | 0.0005 | 100.0% |
| 3 Months | 0.0011 | 0.0012 | 0.0001 | 0.0008415 | 2,160,187 | -0.0001 | -9.09% |
| 6 Months | 0.0011 | 0.0018 | 0.0001 | 0.0010293 | 3,342,142 | -0.0001 | -9.09% |
| 1 Year | 0.0019 | 0.0031 | 0.0001 | 0.0012814 | 3,403,391 | -0.0009 | -47.37% |
| 3 Years | 0.0005 | 0.02 | 0.0001 | 0.0038673 | 76,771,449 | 0.0005 | 100.0% |
| 5 Years | 0.0005 | 0.02 | 0.0001 | 0.0035869 | 50,903,875 | 0.0005 | 100.0% |
ProText Mobility (PK) Description
| Protext is a Biotech Company developing a Hemp/CBD -- Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes & technologies. Through its wholly owned subsidiary RSAMMD Acquisitions LLC ("RSAMMDA") and under the leadership of its founders Mr. Dylon Du Plooy and Dr. Ahmed Jamaloodeen we partner with leading hospitals and universities globally to advance the clinical benefits and applications of cannabinoids. Mr. Du Plooy is a South African pioneer in the research, cultivation, production and distribution of medical cannabis and cannabinoids. Dr. J operates a 5000-hectare farm in New Castle, South Africa and holds cannabis and hemp licenses issued by the Government of South Africa. Together the RSAMMDA founders have been at the forefront of medical cannabis legislation and South African cannabis legalization, which took place in September 2018. We are committed to the advancement of technology and scientific research that leads to an improved quality of life for patients around the world. |
